Edge Therapeutics, Inc. (Nasdaq: EDGE) to Ring The Nasdaq Stock Market Closing Bell


ADVISORY, Aug. 19, 2016 (GLOBE NEWSWIRE) --

What: 
Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, Brian Leuthner, President and CEO, and Dr. R. Loch Macdonald, Chief Scientific Officer, will ring the Closing Bell. 

Where: 
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When: 
Monday, August 22, 2016 – 3:45 p.m. to 4:00 p.m. ET   

Edge Therapeutics, Inc. Contact: 
Gregory Gin
(800) 208-3343 
ir@edgetherapeutics.com

Nasdaq MarketSite: 
Emily Pan
(646) 441-5120 
emily.pan@nasdaq.com

Feed Information: 
Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK

Social Media: 
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: 
http://www.facebook.com/NASDAQ.

For photos from ceremonies and events, please visit our Instagram page: 
http://instagram.com/nasdaq

For livestream of ceremonies and events, please visit our YouTube page: 
http://www.youtube.com/nasdaq/live

For news tweets, please visit our Twitter page: 
http://twitter.com/nasdaq

For exciting viral content and ceremony photos, please visit our Tumblr page: 
http://nasdaq.tumblr.com/

Webcast:
A live stream of the Nasdaq Closing Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos:
To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice.   

About Edge Therapeutics, Inc. 
Edge Therapeutics, Inc. (Edge) is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms for the management of acute, life-threatening neurological conditions. EG-1962, Edge’s lead product candidate, has the potential to fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. For additional information about Edge, please visit www.edgetherapeutics.com.    

About Nasdaq 
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.3 trillion and nearly 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

-NDAQA-

 


Tags